What Is At-Home Ketamine Therapy?
Over the past several years, a number of telehealth companies have begun offering ketamine for at-home use. The typical model works like this: you have a video consultation with a prescriber, and if approved, a compounding pharmacy mails oral or sublingual ketamine tablets (sometimes called troches or lozenges) to your home. You then take the medication on your own, sometimes with a virtual check-in afterward.
These services have made ketamine more accessible for many people. The convenience of treatment at home, the lower per-session cost, and the elimination of travel are genuine advantages.
However, the FDA has raised specific concerns about this model that are worth understanding before you decide which approach is right for you.
What Has the FDA Said About At-Home Ketamine?
The FDA has issued a safety communication warning patients and healthcare providers about potential risks associated with compounded ketamine products. The key concerns include:
- No FDA-approved ketamine product exists for at-home psychiatric use. Compounded ketamine is prepared by compounding pharmacies and has not undergone the same review process as FDA-approved medications.
- Adverse events, including deaths. The FDA has received reports of serious adverse events, including fatalities, associated with unsupervised ketamine use outside of clinical settings.
- Variable potency and quality. Compounded products are not subject to the same manufacturing standards as commercially produced medications. Dosing consistency can vary between batches.
- Lack of medical monitoring. Ketamine can cause changes in blood pressure, heart rate, breathing, and consciousness. Without a trained provider present, these effects may go unnoticed.
The FDA is aware of patients being treated with compounded ketamine products for psychiatric disorders and has concerns about the risks of these products being used without adequate monitoring. — U.S. Food and Drug Administration
This does not mean that every at-home ketamine experience is dangerous. Many patients have used these services without incident. But the FDA warning reflects real concerns about what can happen when a potent anesthetic medication is used without direct clinical oversight.
How Does In-Clinic IV Ketamine Differ?
In-clinic IV ketamine is a fundamentally different treatment experience, even though the active medication is the same molecule.
At Music City Ketamine, every session is administered by Marla Peterson, CRNA, a Certified Registered Nurse Anesthetist with over 20 years of anesthesia experience. The differences are meaningful:
- 100% bioavailability. IV administration delivers the full dose directly into your bloodstream. There is no absorption variability from digestive processes, saliva dilution, or swallowing the medication prematurely.
- Real-time dose adjustment. Marla can increase or decrease the infusion rate during your session based on how you are responding. This precision is not possible with a pre-dosed tablet.
- Continuous monitoring. Your blood pressure, heart rate, and oxygen levels are monitored throughout the session with the same equipment used in operating rooms. If any values move outside normal ranges, Marla can respond immediately.
- Clinical setting. You are in a private treatment room with a trained anesthesia provider present. If you experience nausea, anxiety, or any unexpected reaction, help is right there.
- A calm, supported environment. Our Cool Springs clinic is designed for comfort. Walter White and Wilma, our therapy dogs, are part of the experience for patients who want them there.
The difference is not just medical—it is experiential. Many patients report that knowing a trained provider is present allows them to relax more deeply into the session, which may itself contribute to better outcomes.
How Does Bioavailability Affect Your Treatment?
Bioavailability is the percentage of a medication that actually reaches your bloodstream and produces an effect. This is one of the most important practical differences between at-home and in-clinic ketamine.
- IV ketamine: 100% bioavailability. Every milligram prescribed reaches your system.
- Sublingual ketamine: approximately 25-29% bioavailability. The medication is absorbed through the tissue under your tongue, but absorption depends on how long you hold it, saliva production, and whether any is swallowed.
- Oral ketamine (swallowed): approximately 17-24% bioavailability. Most of the medication is broken down by the liver in what is called first-pass metabolism before it reaches the brain.
What this means in practice: to achieve similar blood levels, an oral dose must be significantly higher than an IV dose. Higher oral doses increase the total amount of ketamine your liver processes, which raises questions about long-term tolerability that researchers are still studying.
It also means that the therapeutic experience can vary significantly from session to session with oral formulations, depending on factors like food intake, hydration, and how the medication is held in the mouth. IV delivery eliminates these variables entirely.
At-Home vs In-Clinic: Side-by-Side Comparison
| Factor | At-Home (Oral/Sublingual) | In-Clinic IV |
|---|---|---|
| Bioavailability | 17–29% | 100% |
| Dosing precision | Fixed tablet dose | Adjustable in real time |
| Medical monitoring | None during session | Continuous (CRNA present) |
| FDA safety concerns | Active warnings issued | Administered per clinical protocols |
| Provider present | No (video check-in only) | Yes (Marla Peterson, CRNA) |
| Session consistency | Variable (absorption differs) | Highly consistent |
| Typical cost | $150–$350/month | $475 per session |
| Convenience | At home, no travel | In-clinic visit required |
| Emergency response | Call 911 | Immediate clinical intervention |
| Medication source | Compounding pharmacy | FDA-approved injectable |
Who Might Consider At-Home Ketamine?
We want to be fair about this. There are situations where at-home ketamine has a role:
- Patients in rural areas without access to an in-clinic provider within a reasonable distance.
- Maintenance dosing for patients who have completed an initial in-clinic series and are using low-dose oral ketamine to extend their improvement between booster sessions.
- Patients with mobility limitations that make regular clinic visits genuinely difficult.
If you fall into one of these categories, at-home ketamine prescribed by a careful provider who requires regular check-ins and appropriate screening may be a reasonable option. The key is finding a provider who takes the prescribing seriously—not one that treats it as a volume business.
What Should You Ask Before Starting Any Ketamine Treatment?
Whether you are considering at-home or in-clinic ketamine, these questions can help you evaluate the quality of care:
- Who is prescribing? What are their credentials and experience with ketamine specifically?
- What monitoring happens during treatment? If the answer is "none" or "a video call after," understand what that means if you have an unexpected reaction.
- Where does the medication come from? Compounding pharmacies vary significantly in quality. FDA-approved injectable ketamine used in clinic settings has a known and consistent potency.
- What happens if something goes wrong? In a clinic with a CRNA, the answer is immediate clinical intervention. At home alone, the answer is calling 911.
- What is the long-term plan? Ongoing, escalating at-home use without a clear treatment plan and regular reassessment is a red flag.
How We Approach This at Music City Ketamine
We chose the in-clinic IV model because we believe it provides the safest, most effective form of ketamine therapy available. Every session at our Cool Springs location includes:
- One-on-one care with Marla Peterson, CRNA, who has administered thousands of anesthetics over her career
- Continuous blood pressure, heart rate, and oxygen monitoring
- Real-time dose adjustment based on your response
- A private treatment room designed for comfort and calm
- A clear treatment plan with defined protocols and regular reassessment
We understand that the cost of in-clinic treatment is higher than at-home options. At $475 per session, it is a meaningful investment. We provide superbills for potential insurance reimbursement and offer financing through Advance Care.
If you are currently using at-home ketamine and wondering whether in-clinic treatment might produce better results, or if you have safety concerns about your current protocol, we are happy to discuss your situation. A consultation is always free, and there is no pressure to commit.